Facebook Linkedin Twitter
Inside Precision Medicine International Survey Highlights Suboptimal Uptake of Lung Cancer Biomarker Testing

Reimbursement

Lungs filled with people
News & Features

International Survey Highlights Suboptimal Uptake of Lung Cancer Biomarker Testing

Laura Cowen
0
Julia Vitarello and her daughter Mila
News & Features

Building a Bridge Between Rare Disease Patients and the Technologies that Could Help Them

Laura Cowen
0
Rare Parents Tackling Rare Diseases
News & Features

Rare Parents Tackling Rare Diseases

Chris Anderson
0
Nurse with masks
Coronavirus

Valunomics: Key Lessons from Covid—We Need to Value Diagnostics

Hannah Mamuszka
0
Genetic research, liquid biopsy conceptual illustration
Molecular Dx

Agendia to Distribute Inivata’s RaDaR MRD and Cancer Recurrence LBx in U.S. and Europe

0
Genetic Counseling for All
News & Features

Genetic Counseling for All

Mike May, PhD
0
Invitae to Acquire Clear Genetics for $50M, Adding Chatbots for Genetic Counseling
News & Features

Invitae to Acquire Clear Genetics for $50M, Adding Chatbots for Genetic Counseling

0
CellMax Life aims to win FDA approval for its circulating tumor cell (CTC) blood test designed to detect colorectal cancer. The test has been marketed for two yers in Asia
Molecular Dx

CellMax Life Launches Clinical Study for Colorectal Cancer CTC Blood Test

0
Myriad Genetics plans to acquire Counsyl for $375 million in cash and stock
Molecular Dx

Myriad to Acquire Counsyl for $375M, Raising Presence in Women’s Health

0
The American Clinical Laboratory Association has sued to block proposed 2018 Medicare payment rates for clinical tests calculated under the Protecting Access to Medicare Act (PAMA). [Source: Clinical Center
Molecular Dx

Clinical Lab Group Sues HHS Over Proposed PAMA 2018 Medicare Rates

Alex Philippidis
0
12Page 1 of 2

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine